-transparent.png){kind=logo}
Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy.
Related Publications
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
March 1982,
Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
October 1985,
Medicina clinica,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
January 1982,
Giornale italiano di cardiologia,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
January 2012,
Therapie,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
March 1983,
Medicina clinica,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
December 1999,
The Journal of veterinary medical science,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
February 1977,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
June 1998,
Indian pediatrics,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
December 1993,
Indian pediatrics,
Thuy D T Vu, and
Suresh Varadarajan, and
Ego Seeman, and
George Jerums, and
Richard J MacIsaac
January 1984,
Journal of cancer research and clinical oncology,
